Aprogen Pharma Announces Termination of Publishing Contract with Subsidiary 'Fortress M'
[Asia Economy Reporter Minji Lee] Aprogen Pharm announced on the 19th that the publishing contract for the mobile game 'Fortress M' by its subsidiary Aprogen Healthcare and Games has been terminated early. The suspension amount is approximately 7.6 billion KRW, accounting for 15% of the recent consolidated gross sales of the parent company.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051414165763158_1778735817.jpg)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- [Breaking] Chung Yongjin Apologizes for Starbucks 'Tank Day' Controversy: "I Take Full Responsibility"
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
The company stated, "Due to the termination of the publishing contract, the subsidiary's service for the game has ended, and sales in the first quarter of this year are expected to decrease." It added, "We plan to compensate for the sales gap by publishing 'Trove' and 'Dragon Raja' Origin, as well as additional new game publishing in the future."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
